Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Aerogen

Explore full profile

High performance aerosol drug delivery | Aerogen

Galway, IrelandFounded 1997Biotech & Life Sciences
Revenue $100–500M Latest reported FY
Headcount 500–1k Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Aerogen and the history behind them.

About Aerogen

Aerogen is a leading manufacturer and distributor of high-performance aerosol drug delivery nebulizers, serving healthcare providers and patients worldwide. The company operates in the medical device market, focusing on innovative solutions for aerosol drug delivery. Aerogen's core products include the Aerogen Solo, Aerogen Ultra, Aerogen Pro, and Pro X Controller, which are designed to deliver medication efficiently and safely to patients, particularly those requiring respiratory support. The company's unique in-line circuit design allows for continuous drug delivery without breaking the ventilation circuit, reducing the risk of contamination and improving patient outcomes. Aerogen's business model involves selling its products through a network of distributors in over 75 countries, generating revenue from product sales and partnerships. The company has played a significant role in addressing global healthcare needs, especially during the COVID-19 pandemic, by providing technology that minimizes the risk of transmission of infectious aerosols.

Source: Dealroom company data

At a glance

Founded
1997
Headquarters
Galway, Ireland
Sector
Biotech & Life Sciences
Power Law
Thoroughbred$100M+ revenue

Investors

1 investor on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series B and later1 investor entered at this stage

  • European Investment Bank
Team profiled 20 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
31 countries with
team presence
🇮🇪 Ireland52.7%
🇺🇸 United States20%
🇮🇳 India3.2%
🇬🇧 United Kingdom3%
🇩🇪 Germany3%
Top 5 of 31 shown
Web traffic by country
22K monthly visits
across markets
🇺🇸 United States28.6%
🇮🇪 Ireland14.5%
🇮🇳 India12.7%
🇨🇦 Canada12.3%
🏳️ Korea11.8%
Top 5 markets shown

Patents

Estimated portfolio value
$2M

0 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Aerogen on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Aerogen on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.